Pfizer’s Hympavzi (marstacimab) has been approved in the European Union (EU) to prevent or reduce the frequency of bleeding episodes in adults and children, ages 12 and older, with severe hemophilia A ...

The decision to discontinue SerpinPC follows the approval of Hympavzi, an antibody-based treatment designed to increase ...

Columnist G Shellye Horowitz's health issues pose challenges during her tap class, but she's resolved to find ways to keep on ...

Metagenomi is preparing to initiate IND-enabling activities that seek to support MGX-001’s transition from preclinical to ...

My wife, Cazandra, had complicated surgery last week that required her to spend some time in the hospital, followed by at least two weeks of inpatient rehabilitation. We were in shock, as we’d thought ...

Caeleb looked up to his big brother, finding comfort in his presence. As the elder sibling, Julian assumed the role of protector, his voice a beacon of reason and compassion for Caeleb in his battles ...

A delayed diagnosis is common for people with acquired hemophilia A (AHA), according to a new study that found that it took ...

As a woman with hemophilia, one of the greatest challenges I face is being believed. This challenge is multifaceted. First, I ...

I can still feel the sting of frustration as I replay that night at the recent National Conference for Women and Teens with hemophilia in Detroit. The conference was a place of empowerment — a chance ...